Tesla
TSLA
Netflix
NFLX
Adobe
ADBE
4
Alphabet-C
GOOG
5
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
TOVX Theriva Biologics
- 1.2453
- +0.0423+3.52%
Trading Mar 25 15:39 ET
3.46MMarket Cap-0.07P/E (TTM)
1.2453High1.1670Low13.59KVolume1.2000Open1.2030Pre Close16.50KTurnover0.57%Turnover RatioLossP/E (Static)2.78MShares12.277552wk High0.18P/B2.99MFloat Cap1.030052wk Low--Dividend TTM2.40MShs Float52089843.7500Historical High--Div YieldTTM6.51%Amplitude1.0300Historical Low1.2130Avg Price1Lot Size
Theriva Biologics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.35%19.43M | -26.33%4.58M | 19.39%5.04M | -24.05%4.42M | 4.13%5.39M | -0.70%21.43M | -15.03%6.22M | -15.40%4.22M | 15.80%5.82M | 21.78%5.18M |
| Selling and administrative expenses | 3.88%7.4M | -16.18%1.69M | 985.85%2.3M | -45.40%1.47M | -12.18%1.93M | -27.77%7.12M | -52.40%2.02M | -91.23%212K | 74.37%2.69M | 32.99%2.2M |
| -General and administrative expense | 3.88%7.4M | -16.18%1.69M | 985.85%2.3M | -45.40%1.47M | -12.18%1.93M | -27.77%7.12M | -52.40%2.02M | -91.23%212K | 74.37%2.69M | 32.99%2.2M |
| Research and development costs | -15.93%12.03M | -31.22%2.89M | -31.75%2.73M | -5.75%2.95M | 16.19%3.46M | 22.08%14.31M | 36.63%4.2M | 55.88%4.01M | -10.10%3.13M | 14.63%2.98M |
| Operating profit | 9.35%-19.43M | 26.33%-4.58M | -19.39%-5.04M | 24.05%-4.42M | -4.13%-5.39M | 0.70%-21.43M | 15.03%-6.22M | 15.40%-4.22M | -15.80%-5.82M | -21.78%-5.18M |
| Net non-operating interest income expense | -51.56%697K | -55.77%138K | -58.64%158K | -54.59%173K | -37.36%228K | 181.05%1.44M | -0.95%312K | 124.71%382K | 1,365.38%381K | 18,100.00%364K |
| Non-operating interest income | -51.56%697K | -55.77%138K | -58.64%158K | -54.59%173K | -37.36%228K | 181.05%1.44M | -0.95%312K | 124.71%382K | 1,365.38%381K | 18,100.00%364K |
| Other net income (expense) | -230,866.67%-6.92M | -25.00%-5K | -47,566.67%-2.85M | -101,625.00%-4.07M | -116.67%-1K | 107.32%3K | -300.00%-4K | 166.67%6K | 55.56%-4K | 126.09%6K |
| Gain on sale of security | -233.33%-4K | -25.00%-5K | -50.00%3K | 75.00%-1K | -116.67%-1K | 107.32%3K | -300.00%-4K | 166.67%6K | 55.56%-4K | 126.09%6K |
| Special income (charges) | ---6.92M | --0 | ---2.85M | ---4.07M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less:Impairment of capital assets | --5.59M | --0 | --1.53M | --4.07M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Write off | --1.33M | --0 | --1.33M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Income before tax | -28.34%-25.65M | 24.74%-4.45M | -101.72%-7.73M | -52.78%-8.32M | -7.43%-5.17M | 5.31%-19.99M | 15.62%-5.91M | 20.62%-3.83M | -8.66%-5.44M | -12.52%-4.81M |
| Income tax | 0 | 0 | 0 | 0 | 0 | -15.09%-1.64M | 24.01%-424K | -57.31%-527K | 32.52%-359K | -330K |
| Net income | -39.81%-25.65M | 18.92%-4.45M | -133.91%-7.73M | -63.57%-8.32M | -15.34%-5.17M | 6.79%-18.35M | 14.90%-5.49M | 26.44%-3.3M | -13.56%-5.08M | -4.80%-4.48M |
| Net income continuous Operations | -39.81%-25.65M | 18.92%-4.45M | -133.91%-7.73M | -63.57%-8.32M | -15.34%-5.17M | 6.79%-18.35M | 14.90%-5.49M | 26.44%-3.3M | -13.56%-5.08M | -4.80%-4.48M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -39.81%-25.65M | 18.92%-4.45M | -133.91%-7.73M | -63.57%-8.32M | -15.34%-5.17M | 6.79%-18.35M | 14.90%-5.49M | 26.44%-3.3M | -13.56%-5.08M | -4.80%-4.48M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -39.81%-25.65M | 18.92%-4.45M | -133.91%-7.73M | -63.57%-8.32M | -15.34%-5.17M | 8.37%-18.35M | 14.90%-5.49M | 31.61%-3.3M | -13.56%-5.08M | -4.80%-4.48M |
| Basic earnings per share | 33.18%-19.03 | 80.27%-1.5982 | -40.41%-6.81 | -26.47%-10.75 | 0.00%-7.5 | 13.04%-28.48 | 26.36%-8.1 | 35.33%-4.85 | -21.43%-8.5 | 3.23%-7.5 |
| Diluted earnings per share | 33.18%-19.03 | 80.27%-1.5982 | -40.41%-6.81 | -26.47%-10.75 | 0.00%-7.5 | 13.04%-28.48 | 26.36%-8.1 | 35.33%-4.85 | -21.43%-8.5 | 3.23%-7.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025